Nike and the Price of Optimism

On December 19, 2024, I bought my first shares of Nike at $77.04.

The reasoning was simple enough that I could have written it on an index card. Nike was the most recognizable athletic brand on earth, with a median return on invested capital above 38% and more than half a century of cultural dominance. The stock had fallen from its all-time high of $179 in November 2021 to the mid-seventies — a decline of nearly 60%. Using the most recently completed fiscal year's earnings of $3.73 per share, the trailing P/E was about 21x. Nike's historical average was closer to 37x.

In other words, I was paying roughly half the multiple that investors had paid for the prior decade. For a franchise of this quality — a brand that had survived bell-bottoms, Reebok Pumps, and Under Armour's brief insurgency — that felt like a margin of safety.

It wasn't. Or more precisely, it wasn't the kind of margin of safety I thought it was.

How the Swoosh Got Scuffed

To understand why Nike was cheap, you need to understand the three years preceding my purchase, because they represent one of the more remarkable cases of a great company sabotaging itself from the inside.

In January 2020, Nike hired John Donahoe as CEO — a tech executive from ServiceNow and eBay, the first outsider to lead the company in its history. His mandate was to accelerate Nike's "Consumer Direct" strategy: sell more through Nike.com and Nike-owned stores, cut out the middlemen. In theory, this meant higher margins, better customer data, and tighter brand control.

In practice, it meant torching the wholesale relationships that had made Nike ubiquitous. Between August 2020 and March 2021, Nike severed ties with at least fifteen major retail partners in two waves — DSW, Urban Outfitters, Zappos, Dillard's, Belk, Bob's Stores, and others. Nike's share of Foot Locker's purchases dropped from 75% to 60%. The shelf space Nike voluntarily abandoned was shelf space it would never easily get back.

The competitors who filled that space were not the usual suspects. Hoka, owned by Deckers Outdoor, had been a niche running brand just a few years earlier. By 2024, it was doing $2.2 billion in annual revenue, growing 59% year-over-year. On Running, the Swiss upstart, crossed $2.6 billion and was growing 38%. New Balance, privately held and unencumbered by quarterly earnings calls, quietly reached a record $7.8 billion. Even Adidas staged a comeback — its Samba and Campus models became the shoes of choice among Gen Z consumers who had grown tired of seeing Air Force 1s on every foot in every airport.

Nike's cultural problem was, in hindsight, predictable. Rather than investing in product innovation, Donahoe's team had leaned heavily on retro models — Air Force 1, Dunk, Air Jordan 1 — because they were cheap to produce and high-margin. But flooding the market with once-exclusive silhouettes destroyed the very scarcity that made them desirable. By 2024, teen surveys showed Nike's brand preference had collapsed: only 38% of retailers cited Nike as their most popular brand for back-to-school, down from 88% just two years earlier.

Meanwhile, China — once Nike's growth engine — was decelerating under a combination of consumer weakness, nationalist sentiment favoring domestic brands like Anta and Li Ning, and the lingering fallout from Xinjiang cotton boycotts. Greater China revenue would eventually post six consecutive quarterly declines.

The Day the Market Lost Patience

The real inflection point came on June 28, 2024.

Nike reported fiscal fourth-quarter earnings that night and the numbers were bad in a way that felt structural rather than cyclical. Revenue fell 2%, missing estimates by $250 million. Nike Direct digital sales — the centerpiece of Donahoe's entire strategy — declined 8%. Converse, Nike's secondary brand, fell 18%. Most damaging was the guidance: management projected mid-single-digit revenue declines for fiscal 2025, against a Wall Street consensus that had expected modest growth.

The stock dropped 20% in a single session — from roughly $94 to $75 — the worst single-day decline in Nike's history as a public company.

Three months later, in September 2024, Nike announced that Donahoe was out. Elliott Hill, a 32-year Nike veteran who had retired in 2020, would return as CEO. The stock popped 8-11% after hours on the news. But the optimism was fragile. In October, Nike withdrew its full-year guidance entirely, citing the CEO transition. In December — the day I made my first purchase — Nike reported another quarter of declines: China revenue down 17%, a new "Win Now" turnaround strategy announced, and the stock slipping another 10%.

What I Thought I Saw

When I bought at $77, here is what the picture looked like from my chair. The trailing P/E, based on the most recent completed fiscal year's earnings of $3.73, was approximately 21x. For context, Nike had traded at an average of 37x over the prior decade. The Swoosh was, by that simple measure, trading at a 43% discount to its own history.

Elliott Hill, a lifelong Nike insider who understood the culture, was now in charge. The DTC strategy was being walked back — Nike was re-engaging with wholesale partners it had abandoned. The brand was still the biggest in the world by revenue. And the stock had already fallen 57% from its high. How much worse could it get?

The thesis felt like classic value investing: great business, temporary problems, cheap price.

What I Missed

Here is what the financial trajectory actually looked like, using Nike's fiscal years ending in May:

The 10-year EPS CAGR was zero. Not low — zero. Nike earned $2.16 per share in fiscal 2016. By fiscal 2025 earnings per share had grown to... checks notes...$2.16. Ouch. In between, Nike saw some earnings growth, especially following the pandemic, but it plateaued at $3.75 in fiscal 2022 and $3.73 in fiscal 2024. So the numbers oscillated, but without compounding. And the fiscal 2025 return to fiscal 2016 levels was a 42% earnings decline.

When I bought at $77 using the trailing P/E of 21x, I was anchoring to the wrong number. The $3.73 in EPS that produced that friendly-looking multiple was already in the rearview mirror. Earnings were in freefall. By the time the fiscal year ending May 2025 was complete, EPS had dropped to $2.16 — which meant my actual purchase price of $77 represented a forward P/E of about 36x, not 21x.

I was buying a cheap stock on expensive earnings. I didn't realize it at the time.

Averaging Down Into the Crater

As the stock continued to decline through early 2025, I averaged down. I knew from the outset I might be early and the stock would continue to decline, so from the initial investment I was always comfortable adding more if the price declined. I felt that it gave me additional margin of safety. I added small positions in February and March as the price declined from $75 to the low $60s. And then in early April 2025, when Trump's "Liberation Day" tariffs sent the market into a panic and Nike cratered into the mid-$50s, I bought aggressively, picking up large blocks at $56, $54, and $53 over the course of several weeks.

By the end of April 2025, I had built Nike into roughly 9% of my portfolio at a weighted average cost around $60.

The additional purchases lowered my cost basis substantially. But it also increased my exposure to a thesis that was, by any honest accounting, not working yet (and uncertain to ever work). I was scaling into conviction before the numbers justified the conviction. That, I would learn, is a separate and important mistake.

What the Multiple Was Really Saying

This is where the lesson gets useful. Because everything I described above - the DTC pivot, the competitive threats, the earnings decline — was knowable. The harder skill, and the one I want to focus on in this post, is learning to read what a P/E multiple is actually telling you. Not as a static number, but as a compressed forecast of the future.

At its simplest, a P/E ratio is just a simple equation that tells an investor how much they have to pay for each dollar of earnings the company generates. That's it. At least on the surface. In reality, it carries more information with it. It is not a measurement of cheapness though. It is the market's encoded answer to three questions: How fast will this company grow? How certain is that growth? And how long can it sustain it? Those three variables mechanically produce the multiple. So when you see a P/E, the right question is never "is 21 high or low?" — it's "what growth rate and certainty level would justify paying 21x?"

Here is a framework for making that explicit. It takes about sixty seconds.

Applied to my Nike position as it stood by early 2026 — roughly $62, with forward EPS estimates around $1.67:

• •Earnings yield: 1 ÷ 37 = 2.7%
• •10-year Treasury: ~4.3%
• •Required return: 10%
• •Implied growth gap: 7.3% annual EPS growth, sustained for years
• •Sanity check: 10-year EPS CAGR = 0.0%. Current trajectory: down 23%

The stock price required 7.3% annual earnings growth from a business that hadn't grown earnings in a decade and was actively contracting. Worse, the earnings yield of 2.7% was below the risk-free rate. A ten-year Treasury would pay me more than Nike's current earnings yield, with zero risk. The only way to justify owning Nike at that price was to believe in a growth resurgence that the numbers flatly contradicted.

I wasn't investing. I was hoping.

The Contrast That Made It Click

The framework becomes even more clarifying when you apply it to a stock on the opposite end of the spectrum. At the same time I was wrestling with Nike, Deckers Outdoor — parent of Hoka, one of the very brands eating Nike's lunch — was trading at roughly 16x forward earnings.

DECK's implied growth gap was 3.75% — and the business had been compounding earnings at nearly 30% annually for a decade. The gap was trivially small relative to the engine underneath it. Even if DECK slowed dramatically, earnings growth alone would close the gap and then some. Time was your friend.

Nike's gap was 7.3% — and the business had compounded at 0% for ten years with current momentum pointing down. The gap required a heroic recovery that hadn't started. Time was your enemy.

Same framework, sixty seconds each, opposite conclusions.

The Three Ways a Gap Closes

Once you see the gap, the next question is: how does it close? There are only three sources of return, and they are not created equal.

Earnings growth is the most reliable and durable. If EPS compounds, the gap closes naturally over time. This is what you want — the business doing the work for you. At DECK, with 29.5% historical EPS growth, this source alone overwhelms the gap.

Dividends are reliable but modest. They close part of the gap with real cash, but they don't compound the business value. Nike's roughly 2.5% dividend yield at my cost basis helped — it brought the effective starting yield to about 5.1% — but it couldn't come close to bridging a 7.3% gap on its own.

Multiple expansion is the least reliable, because it depends entirely on other investors becoming more optimistic. If your return thesis requires the market to re-rate the stock upward — to pay a higher P/E than it does today — you are not investing. You are speculating on sentiment.

For Nike, the honest accounting looked like this:

That 4.8% in required EPS growth sounds modest. But it demands nearly 5% annual growth from a base that was declining 23% and hadn't compounded at all in a decade. The only version of reality where Nike produces that return is one where earnings recover sharply, sustained growth resumes, and the multiple holds steady. All three assumptions had to be right simultaneously.

When you find yourself needing multiple things to go right just to earn a mediocre return, that is the market telling you the price is not justified.

The Value Trap Anatomy

What happened to me with Nike is worth naming precisely, because it's a pattern that will appear again.

I bought at a trailing P/E that looked cheap relative to Nike's historical range. But the earnings that produced that friendly-looking multiple were already declining. As earnings continued to fall, the stock price stabilized — because other investors saw the same apparently cheap multiple and bought the turnaround story. That floor under the price felt reassuring.

It wasn't reassuring. It was dangerous. Here is what was actually happening, quarter by quarter:

• •Price: Roughly flat, then slowly declining
• •Earnings: Falling fast
• •Multiple: Silently expanding
• •Margin of safety: Evaporating without me doing anything

The stock price floor removed my margin of safety before the business earned it back. And that's the cruel irony of owning a beloved brand in decline: the brand's very popularity creates a price floor that prevents you from getting the truly cheap entry you actually need. A stock that keeps falling is painful, but it is potentially gift-wrapping you a better deal. A stock that stabilizes at a middling valuation while earnings deteriorate leaves you stranded — holding a high-multiple stock that you bought as a value play.

Buffett calls this the "earnings denominator" problem, though I suspect he'd use friendlier language. The business deteriorates into an expensive valuation without the stock moving. The result is the same as if you'd bought at 37x from the start, but it feels different, because you remember paying 21x. Your memory of the entry price is real. The margin of safety it seemed to provide was not.

"What the human being is best at doing is interpreting all new information so that their prior conclusions remain intact." — Warren Buffett

The Turnaround Temptation

The natural objection — and the one I made to myself for months — is this: shouldn't I give it more time? Nike is one of the great brands in history. Elliott Hill is a lifer who understands the culture. The DTC overreach is being corrected. The turnaround could work.

Maybe it will. I genuinely believe Nike will remain a dominant global brand for decades. But there is an enormous difference between believing in the business and believing in the stock. Buffett made this point about Coca-Cola and Gillette — he called them "the inevitables." But even he acknowledged that buying inevitables at the wrong price leads to years of dead money. Investors who bought Coca-Cola at peak valuations in 2000 waited over a decade to break even, despite the business being perfectly fine the entire time.

"Wait for the turnaround" only works if you're being paid to wait. At 37x forward earnings on depressed numbers, the market was already pricing in a successful recovery. I wasn't buying optionality cheap. I was paying full price for a turnaround that hadn't happened yet.

A few principles for evaluating turnarounds, arrived at the expensive way:

• •Never anchor to trailing or current EPS. The only number that matters is trough earnings — and you should assume the trough is lower than you expect, because it almost always is. Nike's trough looked like $2.50 from the outside. It printed $2.16 and may go lower.
• •Distinguish cyclical dips from structural erosion. A bad inventory cycle is temporary and self-correcting. Losing cultural relevance with an entire generation of consumers — while three competitors fill the vacuum you created — may not be. Nike has elements of both, which is what makes it genuinely difficult.
• •The stock price floor on beloved brands is not your friend. It keeps you from getting the price that would make the thesis compelling. You want either a clearly cheap price or clear evidence of recovery — not a halfway point between the two.
• •Time is capital. Every year holding a non-compounding position at a full multiple is a year your capital isn't working somewhere else. The opportunity cost is invisible, which is why it's so easy to ignore. But it's real.

The Lesson

Charlie Munger said to invert, always invert. The standard approach to valuation asks: "What do I think this is worth?" The inversion asks: "What does the current price require to be true — and do I believe it?"

A P/E of 16x says the market expects modest growth and has modest confidence. A P/E of 37x says the market expects a heroic recovery and has high confidence in it materializing. Neither number tells you whether the company is good or bad. Both numbers tell you what bet you're placing if you buy at that price.

The framework is simple enough to run in sixty seconds on any stock, and it should become a habit — a mandatory pre-flight check before going deeper:

If the gap requires growth the business hasn't demonstrated, or if you're relying on the market to re-rate the stock upward, you don't have an investment. You have a hope. And hope, as they say in Omaha, is not a strategy.

Nike taught me that. The tuition wasn't cheap. But the lesson — that multiples don't just measure cheapness, they encode expectations, and your job is to read those expectations honestly before you buy — is one I expect to use for the rest of my investing life.